FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3084457963> ?p ?o ?g. }

• W3084457963 endingPage "423" @default.
• W3084457963 startingPage "417" @default.
• W3084457963 abstract "Daratumumab is a CD38-targeting monoclonal antibody with established efficacy and safety in patients with relapsed or refractory multiple myeloma (RRMM). We report results of an early access protocol (EAP) of daratumumab monotherapy for RRMM in a cohort of Brazilian patients.Patients with RRMM and ≥3 prior lines of therapy, including a proteasome inhibitor (PI) and an immunomodulatory drug (IMiD), or who were double refractory to both a PI and IMiD received daratumumab, 16 mg/kg, intravenously weekly for 8 weeks, biweekly for 16 weeks, and every 4 weeks thereafter until disease progression, unacceptable toxicity, loss of clinical benefit, or study conclusion or if daratumumab became available with reimbursement.Forty-nine patients received ≥1 dose of daratumumab. The median (range) duration of treatment was 6.4 (0.3-11.8) months, with a median (range) of 8 (1-13) treatment cycles. Grade 3/4 treatment-emergent adverse events (TEAEs) were reported in 38.8% of patients, most frequently neutropenia and pneumonia (10.2% each). Seven (14.3%) patients discontinued treatment due to TEAEs; 3 patients discontinued due to daratumumab-related TEAEs. Serious TEAEs occurred in 38.8% of patients. Infusion-related reactions were reported in 25 (51.0%) patients, were primarily grade 1/2, and the majority (23 patients) occurred during the first infusion. Twenty (40.8%) patients achieved a partial response or better; median progression-free survival was 8.25 (95% confidence interval, 5.55-17.54) months.In this EAP, daratumumab monotherapy in Brazilian patients showed a safety and efficacy profile consistent with clinical studies of daratumumab monotherapy in patients with heavily pretreated RRMM. ClinicalTrials.gov identifier: NCT02477891." @default.
• W3084457963 created "2020-09-21" @default.
• W3084457963 creator A5007160664 @default.
• W3084457963 creator A5015855770 @default.
• W3084457963 creator A5024217548 @default.
• W3084457963 creator A5044606180 @default.
• W3084457963 creator A5057313667 @default.
• W3084457963 creator A5071336872 @default.
• W3084457963 creator A5071883890 @default.
• W3084457963 creator A5087764727 @default.
• W3084457963 date "2021-10-01" @default.
• W3084457963 modified "2023-10-18" @default.
• W3084457963 title "Results of the daratumumab monotherapy early access treatment protocol in patients from Brazil with relapsed or refractory multiple myeloma" @default.
• W3084457963 cites W1585625390 @default.
• W3084457963 cites W1902692042 @default.
• W3084457963 cites W2003734726 @default.
• W3084457963 cites W2020298011 @default.
• W3084457963 cites W2044436186 @default.
• W3084457963 cites W2062126843 @default.
• W3084457963 cites W2141502099 @default.
• W3084457963 cites W2229483068 @default.
• W3084457963 cites W2400276917 @default.
• W3084457963 cites W2402003835 @default.
• W3084457963 cites W2443548094 @default.
• W3084457963 cites W2486629951 @default.
• W3084457963 cites W2546602163 @default.
• W3084457963 cites W2553693801 @default.
• W3084457963 cites W2588591261 @default.
• W3084457963 cites W2772566228 @default.
• W3084457963 cites W2889295906 @default.
• W3084457963 cites W2890161608 @default.
• W3084457963 cites W2890977830 @default.
• W3084457963 cites W2899788351 @default.
• W3084457963 cites W2905082484 @default.
• W3084457963 cites W2947874495 @default.
• W3084457963 cites W2948728876 @default.
• W3084457963 cites W2966495415 @default.
• W3084457963 doi "https://doi.org/10.1016/j.htct.2020.07.005" @default.
• W3084457963 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8573022" @default.
• W3084457963 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32967807" @default.
• W3084457963 hasPublicationYear "2021" @default.
• W3084457963 type Work @default.
• W3084457963 sameAs 3084457963 @default.
• W3084457963 citedByCount "1" @default.
• W3084457963 countsByYear W30844579632023 @default.
• W3084457963 crossrefType "journal-article" @default.
• W3084457963 hasAuthorship W3084457963A5007160664 @default.
• W3084457963 hasAuthorship W3084457963A5015855770 @default.
• W3084457963 hasAuthorship W3084457963A5024217548 @default.
• W3084457963 hasAuthorship W3084457963A5044606180 @default.
• W3084457963 hasAuthorship W3084457963A5057313667 @default.
• W3084457963 hasAuthorship W3084457963A5071336872 @default.
• W3084457963 hasAuthorship W3084457963A5071883890 @default.
• W3084457963 hasAuthorship W3084457963A5087764727 @default.
• W3084457963 hasBestOaLocation W30844579631 @default.
• W3084457963 hasConcept C121332964 @default.
• W3084457963 hasConcept C126322002 @default.
• W3084457963 hasConcept C141071460 @default.
• W3084457963 hasConcept C142424586 @default.
• W3084457963 hasConcept C197934379 @default.
• W3084457963 hasConcept C2776364478 @default.
• W3084457963 hasConcept C2777063308 @default.
• W3084457963 hasConcept C2777478702 @default.
• W3084457963 hasConcept C2781119759 @default.
• W3084457963 hasConcept C29730261 @default.
• W3084457963 hasConcept C71924100 @default.
• W3084457963 hasConcept C87355193 @default.
• W3084457963 hasConceptScore W3084457963C121332964 @default.
• W3084457963 hasConceptScore W3084457963C126322002 @default.
• W3084457963 hasConceptScore W3084457963C141071460 @default.
• W3084457963 hasConceptScore W3084457963C142424586 @default.
• W3084457963 hasConceptScore W3084457963C197934379 @default.
• W3084457963 hasConceptScore W3084457963C2776364478 @default.
• W3084457963 hasConceptScore W3084457963C2777063308 @default.
• W3084457963 hasConceptScore W3084457963C2777478702 @default.
• W3084457963 hasConceptScore W3084457963C2781119759 @default.
• W3084457963 hasConceptScore W3084457963C29730261 @default.
• W3084457963 hasConceptScore W3084457963C71924100 @default.
• W3084457963 hasConceptScore W3084457963C87355193 @default.
• W3084457963 hasFunder F4320310465 @default.
• W3084457963 hasFunder F4320337601 @default.
• W3084457963 hasIssue "4" @default.
• W3084457963 hasLocation W30844579631 @default.
• W3084457963 hasLocation W30844579632 @default.
• W3084457963 hasLocation W30844579633 @default.
• W3084457963 hasLocation W30844579634 @default.
• W3084457963 hasLocation W30844579635 @default.
• W3084457963 hasOpenAccess W3084457963 @default.
• W3084457963 hasPrimaryLocation W30844579631 @default.
• W3084457963 hasRelatedWork W2010232494 @default.
• W3084457963 hasRelatedWork W2318150798 @default.
• W3084457963 hasRelatedWork W2400769328 @default.
• W3084457963 hasRelatedWork W2403269090 @default.
• W3084457963 hasRelatedWork W2524600754 @default.
• W3084457963 hasRelatedWork W2608137803 @default.
• W3084457963 hasRelatedWork W2911395510 @default.
• W3084457963 hasRelatedWork W2966933292 @default.
• W3084457963 hasRelatedWork W3030219566 @default.

• next